Back

MicroRNA-26b as novel regulator of cardio-metabolic diseases

12 April 2024 (12:00 - 12:15)
Organised by: Logo
Congress Presentation Part of: Metabolic abnormalities in cardiac and vascular diseases: opportunities for new therapies Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Emiel Van der Vorst

RWTH University Hospital Aachen, Aachen (Germany)

3 More presentations in this session

Presentation thumbnail
Innate immune memory in cardiometabolic disease
Professor N. Riksen (Nijmegen, NL)
Slides
Presentation thumbnail
Endothelial metabolism in atherosclerosis
Professor P. Evans (London, GB)
Slides
Presentation thumbnail
A pig model of metabolic factors in INOCA
Professor D. Duncker (Rotterdam, NL)
Slides

Access the full session

Session thumbnail
Metabolic abnormalities in cardiac and vascular diseases: opportunities for new therapies

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Therapeutic potential of extracellular vesicle-mediated miRNA delivery based on liver-heart crosstalk for cardiac injury
thumbnail
Congress Presentation
Identifying potential mirnas and hub genes for coronary artery disease prognosis using integrative approaches
thumbnail
Congress Presentation
Potential implication of microRNA21 and matrix metalloproteinases in myocardial and arterial function in patients with coronary disease and type-2 diabetes at baseline and 1-year follow up

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources